Related Experiment Video
Updated: Jul 21, 2026

Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines
Published on: October 8, 2015
Mutations of the BRAF gene in human cancer
Helen Davies1, Graham R Bignell, Charles Cox
1Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, CB10 1SA, UK.
Abstract:
Cancers arise owing to the accumulation of mutations in critical genes that alter normal programmes of cell proliferation, differentiation and death. As the first stage of a systematic genome-wide screen for these genes, we have prioritized for analysis signalling pathways in which at least one gene is mutated in human cancer. The RAS RAF MEK ERK MAP kinase pathway mediates cellular responses to growth signals. RAS is mutated to an oncogenic form in about 15% of human cancer. The three RAF genes code for cytoplasmic serine/threonine kinases that are regulated by binding RAS. Here we report BRAF somatic missense mutations in 66% of malignant melanomas and at lower frequency in a wide range of human cancers. All mutations are within the kinase domain, with a single substitution (V599E) accounting for 80%. Mutated BRAF proteins have elevated kinase activity and are transforming in NIH3T3 cells. Furthermore, RAS function is not required for the growth of cancer cell lines with the V599E mutation. As BRAF is a serine/threonine kinase that is commonly activated by somatic point mutation in human cancer, it may provide new therapeutic opportunities in malignant melanoma.
Insights
BRAF mutations are common in melanoma and other cancers. These BRAF gene mutations lead to increased kinase activity, driving cancer cell growth and suggesting new therapeutic targets for melanoma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer develops from accumulated gene mutations affecting cell growth and death.
- Signaling pathways with mutated genes in human cancers are prioritized for study.
- The RAS RAF MEK ERK MAP kinase pathway regulates cellular responses to growth signals.
Purpose of the Study:
- To identify genes within signaling pathways mutated in human cancers.
- To investigate the frequency and impact of BRAF mutations in various cancers, particularly melanoma.
Main Methods:
- Systematic genome-wide screening of signaling pathways.
- Analysis of BRAF gene mutations in human cancer samples.
- Functional studies of mutated BRAF proteins in cell lines.
Main Results:
- BRAF somatic missense mutations found in 66% of malignant melanomas.
- Mutations predominantly located in the kinase domain, with V599E being the most common (80%).
- Mutated BRAF proteins exhibit increased kinase activity and transforming potential, independent of RAS signaling.
Conclusions:
- BRAF is frequently activated by somatic point mutations in human cancers.
- Activated BRAF kinase presents potential therapeutic targets for malignant melanoma and other cancers.
More Related Videos
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
06:44Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells
Published on: March 1, 2024
Related Concept Videos
Cancer
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene
Ras is a superfamily...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...